Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

B. Eliasson, D. Moller-Goede, K. Eeg-Olofsson, C. Wilson, J. Cederholm, P. Fleck, M. Diamant, M.R. Taskinen, U. Smith

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)915-925
JournalDiabetologia
Volume55
Issue number4
DOIs
Publication statusPublished - 2012

Cite this